Effectiveness of switching from intravenous to subcutaneous infliximab in Inflammatory Bowel Disease patients: A combined analysis of real-world evidence

F. Cummings, A. Buisson,P. J. Smith,S. Rahmany,S. Subramanian, B. Kwon, S. Park, Y. N. Lee, M. Fumery

JOURNAL OF CROHNS & COLITIS（2024）

Cited 0|Views9

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined